Finch Therapeutics Group, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
12.50
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.37
|
0.00
|
0.37
|
100.00%
|
|
2022-09-30
|
-0.40
|
-0.85
|
-0.45
|
-112.50%
|
|
2022-06-30
|
-0.41
|
-0.48
|
-0.07
|
-17.07%
|
|
2022-03-31
|
0.00
|
-0.52
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.32
|
-0.40
|
-0.08
|
-25.00%
|
|
2021-09-30
|
-0.42
|
-0.21
|
0.21
|
50.00%
|
|
2021-06-30
|
-0.28
|
-0.32
|
-0.04
|
-14.29%
|
|
2021-03-31
|
-0.24
|
-1.00
|
-0.76
|
-316.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.85
|
|
2021-12-31
|
-1.93
|
|
2020-12-31
|
-0.28
|